Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: Predictive factors for local control and late toxicity?

Radiotherapy and Oncology

Volumn 82, Issue 2, 2007, Pages 167-173

  Melzner, Winfrid J ^a   Lotter, Michael ^a   Sauer, Rolf ^a   Strnad, Vratislav ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Head and neck cancer; Late toxicity; Local control; PDR brachytherapy; Quality assessment

Indexed keywords

ADULT; AGED; ARTICLE; BONE NECROSIS; BRACHYTHERAPY; CANCER CONTROL; CANCER RELAPSE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TISSUE NECROSIS; TREATMENT INDICATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MANDIBLE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; OSTEORADIONECROSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SOFT TISSUE INJURIES; TREATMENT OUTCOME;

EID: 33847049447     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.12.004     Document Type: Article

References (39)

1. Ahmad F., Aletti P., Charra-Brunaud C., et al. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy. Radiother Oncol 73 (2004) 331-337
2. Anacak Y., Esassolak M., Aydin A., Aras A., Olacak I., and Haydaroglu A. Effect of geometrical optimization on the treatment volumes and the dose homogeneity of biplane interstitial brachytherapy implants. Radiother Oncol 45 (1997) 71-76
3. Anderson L.L. A "Natural" volume-dose histogram for brachytherapy. Med Phys 13 (1986) 898-903
4. Baltas D., Kolotas C., and Geramani K. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 40 (1998) 515-524
5. Berns C., Fritz P., Hensley F.W., and Wannenmacher M. Consequences of optimization in PDR brachytherapy - is a routine geometrical optimization recommendable?. Int J Radiat Oncol Biol Phys 37 (1997) 1171-1180
6. de Pree C., Popowski Y., Weber D., Nouet P., Rouzaud M., and Kurtz J.M. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 43 (1999) 971-976
7. Fujita M., Hirokawa Y., Kashiwado K., et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 44 (1999) 767-775
8. Fujita M., Hirokawa Y., Kashiwado K., et al. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 34 (1996) 333-339
9. Geiger M., Strnad V., Lotter M., and Sauer R. Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 1 (2002) 149-153
10. Grabenbauer G.G., Rodel C., Brunner T., et al. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlenther Onkol 177 (2001) 338-344
11. Horwitz E.M., Mitra R.K., Uzzo R.G., et al. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol 66 (2003) 173-179
12. ICRU Report 38: Dose and Volume Specification for Reporting Intracavitary Therapy in Gynaecology. ICRU Report 1985.
13. Jereczek-Fossa B.A., and Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28 (2002) 65-74
14. Lapeyre M., Bollet M.A., Racadot S., et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 26 (2004) 216-223
15. Levendag P.C., Schmitz P.I., Jansen P.P., et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 38 (1997) 497-506
16. Major T., Polgar C., Fodor J., Somogyi A., and Nemeth G. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems. Radiother Oncol 62 (2002) 103-111
17. Major T., Polgar C., Somogyi A., and Nemeth G. Evaluation of the dose uniformity for double-plane high dose rate interstitial breast implants with the use of dose reference points and dose non-uniformity ratio. Radiother Oncol 54 (2000) 213-220
18. Matsuura K., Hirokawa Y., Fujita M., Akagi Y., and Ito K. Treatment results of stage I and II oral tongue cancer with interstitial brachytherapy: maximum tumor thickness is prognostic of nodal metastasis. Int J Radiat Oncol Biol Phys 40 (1998) 535-539
19. Mazeron J.J., Noel G., and Simon J.M. Head and neck brachytherapy. Semin Radiat Oncol 12 (2002) 95-108
20. Meertens H, Borger J, Steggerda M, Blom A. Evaluation & Optimisation of Interstitial Brachytherapy Dose Distributions. In: Mould RF, Battermann JJ, Martinez AA, Speiser BL editors. Brachtherapy from Radium to Optimiziation. 1994;300-7.
21. Nose T., Peiffert D., Lapeyre M., Hoffstetter S., Koizumi M., and Nishiyama K. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?. Strahlenther Onkol 180 (2004) 776-782
22. Notani K., Yamazaki Y., Kitada H., et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 25 (2003) 181-186
23. Panitsa E., Rosenwald J.C., and Kappas C. Quality control of dose volume histogram computation characteristics of 3D treatment planning systems. Phys Med Biol 43 (1998) 2807-2816
24. Panitsa E., Rosenwald J.C., and Kappas C. Developing a dose-volume histogram computation program for brachytherapy. Phys Med Biol 43 (1998) 2109-2121
25. Peiffert D., Castelain B., Thomas L., Ardiet J.M., Baillet F., and Mazeron J.J. Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group. Radiother Oncol 58 (2001) 71-75
26. Pernot M., Hoffstetter S., and Peiffert D. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation. Otolaryngol Head Neck Surg 115 (1996) 519-526
27. Polgar C., Major T., Somogyi A., et al. CT-image-based conformal brachytherapy of breast cancer. The significance of semi-3-D and 3-D treatment planning. Strahlenther Onkol 176 (2000) 118-124
28. Pop L.A., van den Broek J.F., Visser A.G., and van der Kogel A.J. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy. Radiother Oncol 38 (1996) 153-162
29. Saw C.B., and Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 20 (1991) 135-139
30. Simon J.M., Mazeron J.J., Pohar S., et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 26 (1993) 19-25
31. Strnad V. Treatment of oral cavity and oropharyngeal cancer indications, technical aspects, and results of interstitial brachytherapy. Strahlenther Onkol 180 (2004) 710-717
32. Strnad V., Geiger M., Lotter M., and Sauer R. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2 (2003) 158-163
33. Strnad V., Lotter M., Grabenbauer G., and Sauer R. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys 46 (2000) 27-30
34. Thomadsen BR: Achieving quality in brachytherapy. Chapter 3: Quality management for a treatment plan. IOP Publishing 2000.
35. Umeda M., Komatsubara H., Nishimatsu N., Yokoo S., Shibuya Y., and Komori T. High-dose rate interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 667-670
36. Van der Laarse R., and Prins T.P.E. Comparing the stepping source dosimetry system and the Paris system using volume-dose histograms in breast implnmats. In: Mould R.F., Battermann J.J., Martinez A.A., and Speiser B.L. (Eds). Brachytherapy from radium to optimization Veenendaal (1994), Nucletron BV, The Netherlands 352-372
37. Van Gellekom M.P., Moerland M.A., Wijrdeman H.K., and Battermann J. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. Radiother Oncol 73 (2004) 49-56
38. Visser A.G., vanden Aardweg G.J., and Levendag P.C. Pulsed dose rate and fractionated high dose rate brachytherapy :choice of brachytherapy schedules to replace low dose rate treatments. Int J Radiat Oncol Biol Phys 34 (1996) 497-505
39. Wu A., Ulin K., and Sternick E.S. A dose homogeneity index for evaluating 192Ir interstitial breast implants. Med Phys 15 (1988) 104-107